Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...

Significant Gaps in Quality Management for 3D Models: Most states do not have clear processes for managing 3D model quality, even when their quality management processes for 2D plan development are ...